{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:30:23Z","timestamp":1761093023532,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.urolonc.2020.11.032","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T23:33:18Z","timestamp":1608161598000},"page":"300.e1-300.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup"],"prefix":"10.1016","volume":"39","author":[{"given":"Jamie S.","family":"Pak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Pina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.11.032_bib0001","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0090-4295(01)00919-0","article-title":"Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy\u2013part I: definition, detection, prevalence, and etiology","volume":"57","author":"Grossfeld","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0002","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.292.6521.681","article-title":"Importance of occult haematuria found at screening","volume":"292","author":"Ritchie","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0003","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.1986.03380020086028","article-title":"Asymptomatic microhematuria and urologic disease","volume":"256","author":"Mohr","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrurol.2010.27","article-title":"Evaluation of asymptomatic, atraumatic hematuria in children and adults","volume":"7","author":"Tu","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/iju.12697","article-title":"Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population","volume":"22","author":"Kang","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0006","doi-asserted-by":"crossref","first-page":"10.e1","DOI":"10.1016\/j.urolonc.2017.09.011","article-title":"Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria","volume":"36","author":"Samson","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0007","unstructured":"Microhematuria: AUA\/SUFU Guideline. Available at: https:\/\/www.auanet.org\/guidelines\/microhematuria. Accessed September 18, 2020."},{"key":"10.1016\/j.urolonc.2020.11.032_bib0008","unstructured":"Microhematuria: Asymptomatic - American Urological Association. Available at: https:\/\/www.auanet.org\/guidelines\/asymptomatic-microhematuria-(amh)-guideline. Accessed January 2, 2020."},{"key":"10.1016\/j.urolonc.2020.11.032_bib0009","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamainternmed.2017.0739","article-title":"Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria","volume":"177","author":"Halpern","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.urolonc.2020.11.032_bib0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.juro.2018.04.065","article-title":"Can renal and bladder ultrasound replace computerized tomography urogram in patients investigated for microscopic hematuria?","volume":"200","author":"Tan","year":"2018","journal-title":"J. Urol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2019.01.011","article-title":"The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria","volume":"126","author":"Gonzalez","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0012","first-page":"5525","article-title":"The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-up","volume":"33","author":"Pichler","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0013","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.urology.2009.06.107","article-title":"Long-term outcome of patients with a negative work-up for asymptomatic microhematuria","volume":"75","author":"Madeb","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0014","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.5489\/cuaj.3583","article-title":"Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015","volume":"10","author":"Kassouf","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bju.14016","article-title":"Guideline of guidelines: asymptomatic microscopic haematuria","volume":"121","author":"Linder","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0016","unstructured":"N.I.C.E. Suspected cancer: recognition and referral 2015. Available at: https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/1-Recommendations-organised-by-site-of-cancer. Accessed April 10, 2020."},{"key":"10.1016\/j.urolonc.2020.11.032_bib0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-5347(17)39379-5","article-title":"Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients","volume":"144","author":"Murakami","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2010.09521.x","article-title":"Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up","volume":"107","author":"Edwards","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0019","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-5347(17)38331-3","article-title":"Long-term followup of asymptomatic microhematuria","volume":"145","author":"Howard","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.urolonc.2020.11.032_bib0020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/cncr.22224","article-title":"Long-term outcome of hematuria home screening for bladder cancer in men","volume":"107","author":"Messing","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-5347(01)67224-0","article-title":"Hematuria home screening: repeat testing results","volume":"154","author":"Messing","year":"1995","journal-title":"J. Urol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0022","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eururo.2018.03.008","article-title":"Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients","volume":"74","author":"Tan","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0023","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamainternmed.2019.2280","article-title":"Comparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuria","volume":"179","author":"Georgieva","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.urolonc.2020.11.032_bib0024","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.juro.2018.05.118","article-title":"Risk of radiation from computerized tomography urography in the evaluation of asymptomatic microscopic hematuria","volume":"200","author":"Yecies","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.urolonc.2020.11.032_bib0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2214\/AJR.14.12825","article-title":"Yield of urinary tract cancer diagnosis with repeat CT urography in patients with hematuria","volume":"204","author":"Mullen","year":"2015","journal-title":"AJR Am J Roentgenol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920306207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920306207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:30Z","timestamp":1761041970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920306207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1078143920306207"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.11.032","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}